The First Staked Injective ETF Starts Trading Today. Can INJ Reach $20 by 2027?
14 Articles
14 Articles
The First Staked Injective ETF Starts Trading Today. Can INJ Reach $20 by 2027?
Injective just gained a Wall Street doorway while Bitcoin and Ethereum slide. But XRP and TRON showed that an ETF launch can fizzle fast, so what would it take for INJ to turn this debut into a real breakout?
Canary Capital launched in Nasdaq the INJC fund, which offers exposure to INJ and seeks to reflect in its liquidative value the net rewards of the stacking. The debut coincides with the advance of Injective in tokenization and with two other ETF proposals linked to the token.
Key points of the news: Canary Capital's Staked INJ ETF got approval to be listed in Nasdaq, moving forward with a product that combines Injective exposure and stacking rewards. The fund plans to keep at least 90% of its INJ stacking, with BitGo as custodian and an annual 1.10% commission. Injective ... Read more
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium










